Phlebologie, Table of Contents Phlebologie 2006; 35(06): 279-280DOI: 10.1055/s-0037-1622154 Editorial Schattauer GmbH Wer braucht eigentlich eine Thromboembolieprophylaxe? Hans Stricker Recommend Article Abstract Buy Article Full Text References Literatur 1 Bergmann JF, Mouly S. Thromboprophylaxis in medical patients: focus on France. Semin Thromb Hemost 2002; 28 (03) 51-5. 2 Chopard P, Dorffler-Melly J, Hess U. et al. Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. J Intern Med 2005; 257: 352-7. 3 Dunn AS, Brenner A, Halm EA. The magnitude of an iatrogenic disorder: A systematic review of the incidence of venous thromboembolism for general medical inpatients. Thromb Haemost 2006; 95: 758-62. 4 Gatt ME, Paltiel O, Bursztyn M. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort study. Thromb Haemost 2004; 91: 538-43. 5 Geerts WH, Pineo GF, Heit JA. et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (03) 338S-400S. 6 Hull RD, Schellong SM, Tapson VF. et al. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study. J Thromb Thrombolysis 2006; 22: 31-8. 7 Kröger K, Paar DW. Thromboprophylaxis with enoxaparin in Germany. Two surveys totalling 13 165 acutely ill medical outpatients. Phlebologie 2006; 35: 281-5. 8 Lederle FA, Sacks JM, Fiore L. et al. The prophylaxis of medical patients for thromboembolism pilot study. Am J Med 2006; 119: 54-9. 9 Leizorovicz A, Cohen AT, Turpie AG. et al. PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-9. 10 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73. 11 Samama MM, Cohen AT, Darmon JY. et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800. 12 Spyropoulos AC. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest 2005; 128: 958-69.
